Fertility preservation and refreezing of transplanted ovarian tissue—a potential new way of managing patients with low risk of malignant cell recurrence

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

  • Stine Gry Kristensen
  • Veronica Giorgione
  • Peter Humaidan
  • Birgit Alsbjerg
  • Anne Mette Bay Bjørn
  • Erik Ernst
  • tcg964, tcg964

Objective To report the first successful refreezing of ovarian tissue recovered more than 3 years after transplantation in a woman previously treated for early-stage ovarian cancer. Design Evaluation of cryopreserved and grafted ovarian tissue. Setting University hospital. Patient(s) A 23-year-old woman diagnosed with stage 1C ovarian mucinous cystadenocarcinoma. Intervention(s) The patient underwent ovarian tissue cryopreservation for fertility preservation and subsequent heterotopic transplantation for fertility restoration 9 years after freezing. After a successful IVF twin pregnancy, grafted tissue was laparoscopically removed for safety reasons. The recovered tissue was refrozen. Main Outcome Measure(s) Live birth and histologic evaluation of the distribution of pre-antral follicle stages. Result(s) The previously grafted ovarian tissue was successfully refrozen, presenting follicular survival 4 weeks after xenografting. The follicular distribution in the recovered grafts showed a shift toward growing-stage follicles compared with the fresh tissue. The patient subsequently entered menopause, and histologic evaluation revealed a total of five follicles in two remaining grafts which had supported ovarian function a few months earlier. Conclusion(s) This is the second case of delivery following heterotopic grafting as well as the second case of successful transplantation of ovarian tissue from a patient with early-stage ovarian cancer. The recovered grafts showed that a lower number of functional follicles than previously estimated can actually support ovarian function. Removing and refreezing grafted tissue could be a new way of handling not only cancer patients with a risk of malignant cell recurrence, but also certain groups of patients with genetic conditions.

OriginalsprogEngelsk
TidsskriftFertility and Sterility
Vol/bind107
Udgave nummer5
Sider (fra-til)1206-1213
Antal sider8
ISSN0015-0282
DOI
StatusUdgivet - maj 2017

ID: 196711334